LBX2 and colorectal cancer: For example, LBX2-AS1 was observed to suppress miR-491-5p function in ovarian cancer, colorectal cancer, gastric cancer, and glioma [5–8], thereby upregulating oncogenes and mediating the malignant phenotypes.